
    
      Primary Objective:

      To determine if a treatment algorithm using serial transvaginal ultrasound with a tumor
      morphology index can improve the positive predictive value (PPV) of ovarian cancer screening
      compared to a historical control from 15% to 25%.

      Secondary Objective To measure the compliance for study participants enrolled on the
      treatment algorithm using serial transvaginal ultrasound with a tumor morphology index.

      Exploratory Objective To determine the effectiveness of a treatment algorithm that combines
      serum biomarkers aloneor in combination with transvaginal ultrasound to reduce the false
      positive rate of ovarian cancer screening in the subset of women agreeing to biomarker
      collection.
    
  